Henriette Farkas Selected Research

icatibant

1/2021	Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema.
1/2018	Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years.
11/2017	Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
8/2016	First report of icatibant treatment in a pregnant patient with hereditary angioedema.
6/2016	Icatibant as acute treatment for hereditary angioedema in adults.
1/2015	Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3.
3/2012	Home treatment of hereditary angioedema with icatibant administered by health care professionals.
12/2011	Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.
8/2010	Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henriette Farkas Research Topics

Disease

88	Hereditary Angioedemas 03/2022 - 12/2003
32	Angioedema 01/2022 - 09/2004
12	Edema (Dropsy) 06/2021 - 12/2003
5	Rare Diseases (Rare Disease) 11/2021 - 01/2011
4	Acquired angioedema 01/2021 - 05/2006
3	Hypersensitivity (Allergy) 04/2021 - 01/2019
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 10/2011
3	Atherosclerosis 01/2019 - 04/2005
3	Neoplasms (Cancer) 03/2011 - 01/2008
2	Infections 04/2022 - 07/2010
2	Inflammation (Inflammations) 04/2022 - 02/2012
2	Anaphylaxis (Anaphylactic Shock) 02/2014 - 01/2011
2	Seasonal Allergic Rhinitis (Hay Fever) 05/2003 - 08/2002
1	Helicobacter Infections 04/2022
1	Insulin Resistance 04/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Erythema 06/2021
1	Vomiting 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Back Pain (Backache) 01/2021
1	Diarrhea 01/2021
1	Thromboembolism 03/2016
1	Polycythemia (Erythrocytosis) 02/2016
1	Cardiac Arrhythmias (Arrythmia) 01/2015
1	Chest Pain (Chest Pains) 01/2015
1	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2014
1	Adrenal incidentaloma 01/2014
1	Pruritus (Itching) 04/2013

Drug/Important Bio-Agent (IBA)

21	BradykininIBA 12/2021 - 12/2011
16	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 12/2003
11	Complement System Proteins (Complement)IBA 01/2021 - 06/2003
10	Danazol (Azol)FDA LinkGeneric 01/2019 - 04/2005
9	icatibantIBA 01/2021 - 08/2010
7	AntibodiesIBA 01/2022 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 04/2022 - 12/2003
6	AndrogensIBA 01/2022 - 07/2010
6	Pharmaceutical PreparationsIBA 04/2021 - 04/2010
5	Plasma KallikreinIBA 06/2021 - 01/2018
5	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 01/2008
4	Factor XII (Hageman Factor)IBA 11/2021 - 07/2010
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 04/2016
4	conestat alfaIBA 03/2020 - 11/2008
4	AutoantibodiesIBA 10/2016 - 02/2007
3	berotralstatIBA 06/2021 - 01/2018
3	Kallikreins (Kallikrein)IBA 01/2020 - 01/2018
3	C-Reactive ProteinIBA 01/2019 - 06/2003
3	Tranexamic Acid (AMCA)FDA Link 03/2016 - 08/2010
3	Histamine Antagonists (Antihistamines)IBA 01/2014 - 05/2003
2	alpha-2-HS-GlycoproteinIBA 04/2022 - 01/2019
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Serine Proteases (Serine Protease)IBA 01/2020 - 10/2015
2	Bradykinin B2 ReceptorIBA 01/2020 - 06/2016
2	LipidsIBA 01/2019 - 04/2005
2	Neutralizing AntibodiesIBA 01/2019 - 02/2014
2	Endothelin-1 (Endothelin 1)IBA 02/2016 - 02/2012
2	LectinsIBA 10/2015 - 12/2014
2	EnzymesIBA 10/2015 - 12/2014
2	Hormones (Hormone)IBA 01/2014 - 09/2004
2	Immunoglobulin G (IgG)IBA 01/2012 - 03/2011
2	Immunoglobulin M (IgM)IBA 10/2011 - 01/2011
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2007 - 08/2002
1	PlasminogenIBA 11/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 11/2021
1	Angiopoietin-1IBA 11/2021
1	Glucosamine (Dona)IBA 11/2021
1	Complement C1 (Complement 1)IBA 08/2021
1	Interleukin-8 (Interleukin 8)IBA 06/2021
1	High-Molecular-Weight Kininogen (Kininogen, High Molecular Weight)IBA 01/2021
1	Platelet Activating FactorIBA 01/2020
1	Cholecalciferol (Vitamin D3)FDA Link 06/2019
1	KininsIBA 02/2019
1	lanadelumabIBA 02/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	acivicin (AT 125)IBA 01/2018
1	Investigational DrugsIBA 01/2018
1	Secretory Phospholipases A2IBA 01/2018
1	Kininogens (Kininogen)IBA 12/2017
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 10/2017
1	Biological ProductsIBA 01/2017
1	Atrial Natriuretic Factor (ANF)IBA 04/2016
1	Testosterone (Sustanon)FDA Link 02/2016
1	AdrenomedullinIBA 02/2016
1	Arginine Vasopressin (Argipressin)IBA 02/2016
1	Thyroid HormonesIBA 01/2016
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2015
1	GlucocorticoidsIBA 01/2014
1	Amino Acids FDA Link 10/2013
1	Histamine (Histamine Dihydrochloride)FDA Link 10/2013
1	Proline (L-Proline)FDA Link 10/2013
1	Mannose-Binding Protein-Associated Serine Proteases (Mannose-Binding Protein-Associated Serine Protease)IBA 07/2013
1	FicolinsIBA 07/2013
1	Estrogens (Estrogen)FDA Link 07/2013

Therapy/Procedure

28	Therapeutics 03/2022 - 08/2002
2	Aftercare (After-Treatment) 02/2016 - 12/2012
1	Polypharmacy 01/2020
1	Biological Therapy 01/2020
1	Oral Administration 01/2018
1	Drug Therapy (Chemotherapy) 04/2013